One Covid drug in approval phase

As of the end of July, one vaccine from China had received limited approval from the Chinese government. CanSinoBIO demonstrated in Phase II trials that its AD5 adenovirus vaccine produced a strong immune response. The Chinese military approved the vaccine July 25 for soldiers.